| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Dec 31, 2021 | Option Exercise | $22.58 | 470 | 10,611 | 27,333 | Jan 04, 2022, 09:10 PM | |
| CDMO | Avid Bioservices, Inc. | Green Nicholas Stewart | President & CEO | Dec 31, 2021 | Option Exercise | $22.58 | 470 | 10,611 | 23,109 | Jan 04, 2022, 09:09 PM | |
| CDMO | Avid Bioservices, Inc. | Ziebell Mark R | V. P., General Counsel | Dec 27, 2021 | Sale | $30.27 | 6,829 | 206,689 | 7,429 | Dec 29, 2021, 07:23 PM | |
| CDMO | Avid Bioservices, Inc. | Ziebell Mark R | V. P., General Counsel | Dec 15, 2021 | Option Exercise | $13.93 | 12,858 | 179,097 | 20,687 | Dec 16, 2021, 09:36 PM | |
| CDMO | Avid Bioservices, Inc. | Hancock Richard B | Director | Dec 01, 2021 | Option Exercise | $17.72 | 10,000 | 177,159 | 37,821 | Dec 03, 2021, 07:12 PM | |
| CDMO | Avid Bioservices, Inc. | Hancock Richard B | Director | Nov 15, 2021 | Sale | $32.39 | 5,013 | 162,392 | 37,821 | Nov 17, 2021, 07:29 PM | |
| CDMO | Avid Bioservices, Inc. | Ziebell Mark R | V. P., General Counsel | Oct 11, 2021 | Sale | $22.37 | 349 | 7,808 | 14,258 | Oct 12, 2021, 05:38 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Oct 11, 2021 | Sale | $22.37 | 760 | 17,002 | 26,863 | Oct 12, 2021, 05:36 PM | |
| CDMO | Avid Bioservices, Inc. | Green Nicholas Stewart | President & CEO | Oct 11, 2021 | Sale | $22.37 | 2,786 | 62,325 | 22,639 | Oct 12, 2021, 05:36 PM | |
| CDMO | Avid Bioservices, Inc. | Green Nicholas Stewart | President & CEO | Aug 02, 2021 | Sale | $25.56 | 18,701 | 477,998 | 19,852 | Aug 03, 2021, 08:17 PM | |
| CDMO | Avid Bioservices, Inc. | Ziebell Mark R | V. P., General Counsel | Jul 12, 2021 | Sale | $25.61 | 7,207 | 184,574 | 15,816 | Jul 13, 2021, 09:40 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Jul 12, 2021 | Sale | $25.61 | 5,409 | 138,528 | 28,553 | Jul 13, 2021, 09:39 PM | |
| CDMO | Avid Bioservices, Inc. | Green Nicholas Stewart | President & CEO | Jun 30, 2021 | Option Exercise | $10.08 | 1,053 | 10,615 | 1,053 | Jul 01, 2021, 04:31 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Jun 30, 2021 | Option Exercise | $10.08 | 1,053 | 10,615 | 20,790 | Jul 01, 2021, 04:31 PM | |
| CDMO | Avid Bioservices, Inc. | Bamforth Mark R | Director | Mar 17, 2021 | Sale | $18.18 | 100,000 | 1,818,000 | 0 | Mar 19, 2021, 05:25 PM | |
| CDMO | Avid Bioservices, Inc. | Bamforth Mark R | Director | Mar 17, 2021 | Buy | $18.18 | 126,000 | 2,290,680 | 126,000 | Mar 19, 2021, 05:25 PM | |
| CDMO | Avid Bioservices, Inc. | Bamforth Mark R | Director | Mar 17, 2021 | Sale | $18.18 | 26,000 | 472,680 | 0 | Mar 19, 2021, 05:25 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Dec 31, 2020 | Option Exercise | $6.06 | 1,754 | 10,623 | 19,737 | Jan 04, 2021, 06:21 PM | |
| CDMO | Avid Bioservices, Inc. | Ziebell Mark R | V. P., General Counsel | Jul 13, 2020 | Sale | $6.88 | 3,683 | 25,339 | 6,829 | Jul 14, 2020, 09:25 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Jul 13, 2020 | Sale | $6.88 | 2,056 | 14,145 | 17,983 | Jul 14, 2020, 09:24 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel R | Chief Financial Officer | Jun 30, 2020 | Option Exercise | $5.58 | 1,691 | 9,436 | 14,173 | Jul 02, 2020, 06:07 PM | |
| CDMO | Avid Bioservices, Inc. | Hancock Richard B | Interim President & CEO | May 07, 2020 | Option Exercise | $6.22 | 1,679 | 10,443 | 25,808 | May 08, 2020, 04:54 PM | |
| CDMO | Avid Bioservices, Inc. | Walsh Patrick D | Director | Mar 23, 2020 | Buy | $3.22 | 30,000 | 96,600 | 30,000 | Mar 25, 2020, 01:09 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel Ryan | Chief Financial Officer | Mar 16, 2020 | Buy | $3.77 | 7,500 | 28,255 | 12,482 | Mar 17, 2020, 12:21 PM | |
| CDMO | Avid Bioservices, Inc. | Hancock Richard B | Interim President & CEO | Mar 13, 2020 | Buy | $3.99 | 12,500 | 49,875 | 22,500 | Mar 16, 2020, 03:25 PM | |
| CDMO | Avid Bioservices, Inc. | CARLEONE JOSEPH | Director | Mar 13, 2020 | Buy | $4.01 | 12,500 | 50,125 | 66,945 | Mar 16, 2020, 03:25 PM | |
| CDMO | Avid Bioservices, Inc. | Bamforth Mark R | Director | Mar 13, 2020 | Buy | $4.01 | 26,000 | 104,260 | 26,000 | Mar 16, 2020, 03:24 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel Ryan | Chief Financial Officer | Oct 31, 2019 | Option Exercise | $3.94 | 2,693 | 10,621 | 4,982 | Oct 31, 2019, 06:54 PM | |
| CDMO | Avid Bioservices, Inc. | Hancock Richard B | Interim President & CEO | Sep 10, 2019 | Buy | $5.09 | 10,000 | 50,910 | 10,000 | Sep 12, 2019, 03:03 PM | |
| CDMO | Avid Bioservices, Inc. | CARLEONE JOSEPH | Director | Sep 10, 2019 | Buy | $5.05 | 10,000 | 50,500 | 54,445 | Sep 12, 2019, 03:03 PM | |
| CDMO | Avid Bioservices, Inc. | Lias Roger J. | President & CEO | Apr 30, 2019 | Option Exercise | $4.07 | 2,289 | 9,320 | 2,289 | Apr 30, 2019, 08:55 PM | |
| CDMO | Avid Bioservices, Inc. | Hart Daniel Ryan | Chief Financial Officer | Apr 30, 2019 | Option Exercise | $4.07 | 2,289 | 9,320 | 2,289 | Apr 30, 2019, 08:53 PM | |
| CDMO | Avid Bioservices, Inc. | McComb Joel | Director | Sep 19, 2018 | Sale | $6.48 | 25,733 | 166,786 | 24,267 | Sep 21, 2018, 06:22 PM | |
| CDMO | Avid Bioservices, Inc. | McComb Joel | Director | Sep 20, 2018 | Sale | $6.57 | 24,267 | 159,500 | 0 | Sep 21, 2018, 06:22 PM | |
| CDMO | Avid Bioservices, Inc. | McComb Joel | Director | Feb 15, 2018 | Buy | $2.25 | 50,000 | 112,500 | 50,000 | Feb 20, 2018, 06:15 PM | |
| CDMO | Avid Bioservices, Inc. | CARLEONE JOSEPH | Director | Feb 15, 2018 | Buy | $2.25 | 44,445 | 100,001 | 44,445 | Feb 20, 2018, 06:14 PM | |
| CDMO | Avid Bioservices, Inc. | Bamforth Mark R | Director | Feb 15, 2018 | Buy | $2.25 | 50,000 | 112,500 | 100,000 | Feb 20, 2018, 06:13 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Shan Joseph | VP, Clinical and Reg Affairs | Oct 31, 2017 | Option Exercise | $3.87 | 2,747 | 10,624 | 16,187 | Nov 01, 2017, 03:13 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2017 | Option Exercise | $3.87 | 1,398 | 5,407 | 34,646 | Nov 01, 2017, 03:12 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Bamforth Mark R | Director | Oct 27, 2017 | Buy | $4.50 | 50,000 | 225,091 | 50,000 | Oct 27, 2017, 06:15 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Shan Joseph | VP, Clinical and Reg Affairs | Apr 28, 2017 | Option Exercise | $0.27 | 39,177 | 10,625 | 94,079 | Apr 28, 2017, 06:58 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Apr 28, 2017 | Option Exercise | $0.27 | 37,389 | 10,140 | 184,038 | Apr 28, 2017, 06:57 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 28, 2017 | Option Exercise | $0.27 | 19,941 | 5,408 | 232,730 | Apr 28, 2017, 06:56 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Shan Joseph | VP, Clinical and Reg Affairs | Oct 31, 2016 | Option Exercise | $0.29 | 33,783 | 9,675 | 54,902 | Nov 01, 2016, 08:06 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Oct 31, 2016 | Option Exercise | $0.29 | 33,783 | 9,675 | 146,649 | Nov 01, 2016, 08:04 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2016 | Option Exercise | $0.29 | 18,826 | 5,392 | 212,789 | Nov 01, 2016, 08:02 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 31, 2016 | Option Exercise | $0.29 | 25,433 | 7,284 | 135,908 | Nov 01, 2016, 07:58 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Shan Joseph | VP, Clinical and Reg Affairs | Apr 29, 2016 | Option Exercise | $0.30 | 10,683 | 3,216 | 21,119 | May 02, 2016, 08:19 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 29, 2016 | Option Exercise | $0.30 | 10,683 | 3,216 | 193,963 | May 02, 2016, 08:19 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 29, 2016 | Option Exercise | $0.30 | 10,683 | 3,216 | 110,475 | May 02, 2016, 08:18 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Oct 30, 2015 | Option Exercise | $0.95 | 6,158 | 5,850 | 112,866 | Nov 02, 2015, 04:17 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 30, 2015 | Option Exercise | $0.95 | 5,474 | 5,200 | 183,280 | Nov 02, 2015, 04:16 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 30, 2015 | Option Exercise | $0.95 | 8,448 | 8,026 | 99,792 | Nov 02, 2015, 04:16 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Apr 30, 2015 | Option Exercise | $1.11 | 5,217 | 5,791 | 106,708 | May 01, 2015, 12:57 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 30, 2015 | Option Exercise | $1.11 | 4,634 | 5,144 | 177,806 | May 01, 2015, 12:57 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 30, 2015 | Option Exercise | $1.11 | 7,179 | 7,969 | 91,344 | May 01, 2015, 12:56 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 31, 2014 | Option Exercise | $1.36 | 5,362 | 7,292 | 84,165 | Nov 04, 2014, 04:40 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2014 | Option Exercise | $1.36 | 3,280 | 4,461 | 173,172 | Nov 04, 2014, 04:40 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 30, 2014 | Option Exercise | $1.11 | 6,571 | 7,294 | 78,803 | May 01, 2014, 09:31 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 30, 2014 | Option Exercise | $1.11 | 4,020 | 4,462 | 169,892 | May 01, 2014, 09:31 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2013 | Option Exercise | $1.08 | 4,131 | 4,461 | 191,534 | Nov 01, 2013, 05:30 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 31, 2013 | Option Exercise | $1.08 | 6,752 | 7,292 | 72,232 | Nov 01, 2013, 05:28 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Apr 30, 2013 | Option Exercise | $0.71 | 11,988 | 8,511 | 101,491 | May 01, 2013, 07:44 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 30, 2013 | Option Exercise | $0.71 | 6,516 | 4,626 | 87,403 | May 01, 2013, 07:42 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 30, 2013 | Option Exercise | $0.71 | 10,481 | 7,442 | 65,480 | May 01, 2013, 07:42 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2012 | Option Exercise | $0.39 | 11,000 | 4,290 | 80,887 | Nov 01, 2012, 05:45 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Oct 31, 2012 | Option Exercise | $0.39 | 20,885 | 8,145 | 89,503 | Nov 01, 2012, 05:43 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 31, 2012 | Option Exercise | $0.39 | 17,980 | 7,012 | 54,999 | Nov 01, 2012, 05:39 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Masten Jeffrey L. | V.P. Quality | Apr 30, 2012 | Option Exercise | $0.40 | 12,498 | 4,999 | 12,498 | May 01, 2012, 08:40 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Apr 30, 2012 | Option Exercise | $0.40 | 12,498 | 4,999 | 68,618 | May 01, 2012, 08:29 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 30, 2012 | Option Exercise | $0.40 | 10,726 | 4,290 | 69,887 | May 01, 2012, 08:28 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 30, 2012 | Option Exercise | $0.40 | 12,498 | 4,999 | 37,019 | May 01, 2012, 08:28 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | SWARTZ ERIC S | Director | Mar 14, 2012 | Buy | $0.62 | 16,000 | 9,934 | 126,000 | Mar 15, 2012, 08:12 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Oct 31, 2011 | Option Exercise | $0.89 | 5,122 | 4,559 | 56,120 | Nov 02, 2011, 03:35 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Oct 31, 2011 | Option Exercise | $0.89 | 4,804 | 4,276 | 59,161 | Nov 02, 2011, 03:34 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Oct 31, 2011 | Option Exercise | $0.89 | 5,122 | 4,559 | 24,521 | Nov 02, 2011, 03:33 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Apr 29, 2011 | Option Exercise | $1.28 | 5,947 | 7,612 | 77,998 | May 03, 2011, 07:42 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Apr 29, 2011 | Option Exercise | $1.28 | 3,046 | 3,899 | 96,357 | May 03, 2011, 07:40 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | Fussey Shelley PM | V.P., Intellectual Property | Apr 29, 2011 | Option Exercise | $1.28 | 5,371 | 6,875 | 34,399 | May 03, 2011, 07:38 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | SWARTZ ERIC S | Director | Nov 08, 2010 | Buy | $1.60 | 10,000 | 15,968 | 110,000 | Nov 09, 2010, 07:10 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Sep 24, 2010 | Buy | $1.34 | 6,684 | 8,957 | 72,051 | Sep 27, 2010, 01:40 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | LYTLE PAUL J | Chief Financial Officer | Sep 23, 2010 | Buy | $1.33 | 5,000 | 6,650 | 65,367 | Sep 24, 2010, 04:37 PM | |
| PPHM | PEREGRINE PHARMACEUTICALS INC | KING STEVEN W | President & CEO | Sep 23, 2010 | Buy | $1.33 | 5,000 | 6,650 | 93,311 | Sep 24, 2010, 04:36 PM |
Menu